Volume 9, Number 7—July 2003
West Nile Virus Infection in Crocodiles
Highlight and copy the desired format.
|EID||Steinman A, Banet-Noach C, Tal S, Levi O, Simanov L, Perk S, et al. West Nile Virus Infection in Crocodiles. Emerg Infect Dis. 2003;9(7):887-889. https://dx.doi.org/10.3201/eid0907.020816|
|AMA||Steinman A, Banet-Noach C, Tal S, et al. West Nile Virus Infection in Crocodiles. Emerging Infectious Diseases. 2003;9(7):887-889. doi:10.3201/eid0907.020816.|
|APA||Steinman, A., Banet-Noach, C., Tal, S., Levi, O., Simanov, L., Perk, S....Shpigel, N. (2003). West Nile Virus Infection in Crocodiles. Emerging Infectious Diseases, 9(7), 887-889. https://dx.doi.org/10.3201/eid0907.020816.|
To the Editor: Recently West Nile virus (WNV) infection has been reported in three alligators (Alligator sp.) from central Florida (1) and one captive crocodile monitor (Varanus salvadori) with neurologic signs from the District of Columbia and Maryland area (2). These first reports of the virus in American reptiles highlight the possible role of this group of vertebrates in the WNV life cycle. To our knowledge, WNV in a reptile was reported only once before in a serosurvey conducted in Israel from 1965 to 1966, in which 22 reptiles and 96 amphibians were tested for hemagglutination-inhibiting antibodies against several viruses, including WNV; one turtle (Clemmys caspica) was seropositive (3). Experimental infection of the lake frog (Rana ridibunda) with a Russian strain of WNV resulted in high levels of viremia (4). At present, the role of reptiles and amphibians in the life cycle and epidemiology of WNV is not known.
We report, for the first time, WNV infection in crocodiles (Crocodylus niloticus). To assess the potential role of crocodiles in the life cycle of WNV in Israel, serum specimens were collected from 20 healthy crocodiles on a commercial farm in the Negev Desert, in southern Israel (31°14′N, 34°19′E). The crocodiles came from two separate breeding farms (32°03′N, 35°26′E and 30°18′N, 35°07′E) in the Syrian-African Rift Valley, which is on the main route of bird migration from Africa to Europe. Five males and 15 females, 1–2.5 years of age, were examined. Blood was withdrawn from the crocodiles’ ventral caudal vein, separated by centrifugation, and kept at –20°C until analyzed. Neutralizing antibody titers were determined against WN-goose-98 (5) and attempts to isolate the virus were performed by using Vero cell culture (6) and by using direct reverse transcription–polymerase chain reaction (RT-PCR) on the serum specimens. To eliminate the possibilities of nonspecific reaction, all serum samples were concurrently tested for the only other flavivirus known to be present in Israel; Israeli turkey meningo-encephalitis virus (ITV) (7). Because ITV does not produce cytopathic effects (CPE) in Vero cells, virus neutralization was conducted on BHK cells for both WNV and ITV by using WN-goose-98 and ITV (vaccine strain). In this case, the virus stocks (10-4.2 50% tissue culture infective dose) were diluted 1:400, and virus neutralization titers were checked 3 days later.
Viral RNA was extracted from serum samples with the QIAamp RNA blood kit (QIAGEN, Valencia, CA) , according to the manufacturer’s protocol and resuspended in 30 μl of RNase-free water. The primer pair WN240-Kun848 (respective genome positions 5′: 848 and 1,645) was used to synthesize an 800-bp product in the E gene region (8,9). The resulting DNA fragment was visualized on 1.5% agarose gel stained with ethidium bromide.
The seroprevalence rate in the first set of virus neutralization assays in Vero cells was 14/20 (70%, with titers ranging from 1:20 to 1:320 [3x1:20, 3x1:40, 3x1:80, 2x1:160, 3x1:320]). No differences were discernible in either the seroprevalence rate or in the average titers of crocodiles from two different breeding farms. In BHK cells, a similar seroprevalence rate was observed, with titers ranging from 1:40 to 1:1,280 (3x1:40, 2x1:80, 1x1:160, 4x1:320, 3x1:640, 1x1:1280). All serum samples, except one, were <1:10 against ITV virus, which had a titer of 1:640 against WNV and 1:10 against ITV. Viremia was not detected in any of the 20 samples in Vero cell culture or by RT-PCR.
These results demonstrate a high rate of infection with WNV in crocodiles in Israel. The crocodiles may have been exposed to the virus during the summer at their present location, since no difference in prevalence was seen between the two groups (which differed only in the farm of origin) and since the younger crocodiles had been hatched in the spring of 2002. Furthermore, a cross-reaction with the other prevalent flavivirus in Israel, ITV, was ruled out. Preliminary results from an equine seroprevalence study (involving 800 horses over a 3-year period) of virus neutralization antibodies to WNV collected during fall 2002, indicate that most horses sampled in Israel’s Arava Valley (a desert in the Syrian-African Rift near the Jordanian and Egyptian borders) and the Gulf of Aqaba/Eilat (30°59′N, 35°18′E to 29°34′N, 34°57′E) (85%, 79/90) were positive (A. Steinman and S. Tal, unpub. data,). WNV was also isolated from mosquitoes in the same region (10). The seroprevalence of WNV antibodies among horses and local birds from the Negev Desert is not known nor is the time when the horses acquired WNV infection. However, the isolation of WNV from mosquitoes (10) and the presence of antibodies to WNV in young crocodiles demonstrate arboviral activity in this region in the summer of 2002, although clinical cases were few. That virus was not isolated from crocodiles in late November (past outbreaks of WNV in Israel mainly occurred between August and October) (6,11).
WNV has been endemic in Israel since the early 1950s (12). More recently, in the summer of 2000, an extensive outbreak occurred, affecting hundreds of people (11), dozens of horses (6), and several flocks of geese (5). However, no deaths of crocodiles were reported. This contrasts with the report from Florida (1), where WNV was isolated from dead alligators, and where hundreds of cases of sudden death had been reported in previous years; these deaths are now suspected to result, at least in part, from WNV disease.
The role of various reptile species in the epidemiology of other arboviruses such as western equine encephalitis, eastern equine ecephalitis, and Venezuelan equine encephalitis is well documented (13–15). At present, the role of reptiles and amphibians in the life cycle and epidemiology of WNV is not known, and further research is necessary.
We thank Kubbi Ofer for assistance in the collection of serum samples from the crocodiles.
- ProMED-mail. Florida: West Nile virus identified in alligators for the first time. ProMED-mail 2002; 14 Nov: 20021114.5797. Available from: http://www.promedmail.org
- Travis D, McNamara T, Glaser A, Campbell R. A national surveillance system for WNV in zoological institutions. Available from: URL: http://www.cdc.gov/ncidod/dvbid/westnile/conf/ppt/1a-travis.ppt
- Nir Y, Lasowski Y, Avivi A, Goldwasser R. Survey for antibodies to arboviruses in the serum of various animals in Israel during 1965–1966. Am J Trop Med Hyg. 1969;18:416–22.
- Kostiukov MA, Gordeeva ZE, Bulychev VP, Nemova NV, Daniiarov OA. The lake frog (Rana ridibunda)—one of the food hosts of blood-sucking mosquitoes in Tadzhikistan—a reservoir of the West Nile fever virus. Med Parazitol (Mosk). 1985;3:49–50.
- Malkinson M, Banet C, Weisman Y, Pokamunski S, King R, Drouet MT, Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis. 2002;8:392–7.
- Steinman A, Banet C, Sutton GA, Yadin H, Hadar S, Brill A. Clinical description of equine West Nile encephalomyelitis during the outbreak of 2000 in Israel. Vet Rec. 2002;151:47–9.
- Ianconescu M. Turkey meningo-encephalitis: a general review. Avian Dis. 1976;20:135–8.
- Berthet FX, Zeller HG, Drouet MT, Rauzier J, Digoutte JP, Deubel V. Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol. 1997;78:2293–7.
- Savage HM, Ceianu C, Nicolescu G, Karabatsos N, Lanciotti RS, Vladimirescu A, Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am J Trop Med Hyg. 1999;61:600–11.
- Ministry of the Environment. State of Israel. Available from: URL: http://www.sviva.gov.il
- Weinberger M, Pitlik SD, Gandacu D, Lang R, Nassar F, Ben David D, West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis. 2001;7:686–91.
- Bernkopf H, Levine S, Nerson R. Isolation of West Nile virus in Israel. J Infect Dis. 1953;93:207–18.
- Bowen GS. Prolonged western equine encephalitis viremia in the Texas tortoise (Gopherus berlandieri). Am J Trop Med Hyg. 1977;26:171–5.
- Thomas LA, Eklund CM, Rush WA. Susceptibility of garter snakes (Thamnophis spp.) to western equine encephalomyelitis virus. Proc Soc Exp Biol Med. 1958;99:698–700.
- Walder R, Suarez OM, Calisher CH. Arbovirus studies in the Guajira region of Venezuela: activities of Eastern equine encephalitis and Venezuelan equine encephalitis viruses during an interepizootic period. Am J Trop Med Hyg. 1984;33:699–707.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Amir Steinman, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, P.O.B. 12, Rehovot 76100, Israel; fax: 972-3-9685839
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 22, 2010
- Page last updated: December 22, 2010
- Page last reviewed: December 22, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)